Cardiff Oncology
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-2.18-1.74-1.21-1.04
Price/Sales ratio
1.46K1.46K1.46K973.55
Earnings per Share (EPS)
$-1.06$-1.33$-1.90$-2.22

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.67-5.15-1.61-0.43-0.45-0.45-19.47-8.45-1.62-1.59-1.67-0.45
Price/Sales ratio
290.31452.04166.3121.2819.6030.231.02K653.39158.13135.49168.3019.60
Price/Book Value ratio
9.732.903.201.650.731.012.931.670.570.940.611.01
Price/Cash Flow ratio
-6.38-6.39-2.04-0.46-0.56-0.55-23.01-10.18-1.80-2.14-1.92-0.55
Price/Free Cash Flow ratio
-6.20-5.80-1.98-0.45-0.56-0.55-22.72-10.09-1.75-2.10-1.86-0.55
Price/Earnings Growth ratio
-0.66-0.13-0.060.000.000.000.290.37-0.07-0.190.080.00
Dividend Yield
28.31%17.13%38.25%225.47%327.12%327.22%6.45%0.01%0.67%N/AN/A327.22%
Profitability Indicator Ratios
Gross Profit Margin
94.64%-100.95%-354.06%-258.61%-57.93%-4456.01%-2969.73%-39.27%48.18%100%N/A-57.93%
Operating Profit Margin
-5337.5%-8074.76%-10536.74%-5068.51%-4511.37%-6807.34%-5214.81%-8037.60%-10337.30%-9305.73%-10337.30%-6807.34%
Pretax Profit Margin
-5116.07%-8776.67%-10289.76%-4932.07%-4354.76%-6699.59%-5275.14%-7880.50%-10026.94%-8492.00%-10026.94%-6699.59%
Net Profit Margin
-5116.07%-8776.67%-10289.76%-4932.07%-4354.76%-6592.65%-5267.84%-7727.57%-9716.58%-8492.00%-10026.94%-6592.65%
Effective Tax Rate
-4.24%-6.60%0.75%-2.87%-3.75%1.59%0.13%1.94%3.09%N/AN/A-3.75%
Return on Assets
-49.57%-38.45%-89.20%-202.74%-116.15%-123.42%-14.31%-18.55%-32.27%-50.76%-33.31%-116.15%
Return On Equity
-171.57%-56.40%-198.32%-382.83%-163.23%-220.92%-15.04%-19.75%-35.26%-59.42%-32.93%-163.23%
Return on Capital Employed
-61.22%-39.96%-111.04%-306.94%-152.16%-200.81%-14.84%-20.18%-36.81%-63.78%-36.81%-152.16%
Liquidity Ratios
Current Ratio
6.178.334.992.394.302.3721.79N/AN/AN/A14.254.30
Quick Ratio
6.178.334.992.394.302.3721.7922.2714.257.4113.584.30
Cash ratio
6.088.224.852.083.862.1321.401.822.092.072.092.13
Days of Sales Outstanding
73.90115.1396.2455.72161.98303.14319.58543.94729.05215.40729.05161.98
Days of Inventory outstanding
-10.36K0.00N/A0.00N/A0.00N/AN/AN/AN/AN/A0.00
Operating Cycle
-10.29K115.1496.2455.72161.98303.14319.58543.94729.05N/AN/A303.14
Days of Payables Outstanding
18.19K604.00238.52166.32406.4721.4644.371.05K3.56KN/AN/A21.46
Cash Conversion Cycle
-28.48K-488.86-142.28-110.60-244.49281.68275.21-506.52-2.84KN/AN/A-244.49
Debt Ratios
Debt Ratio
0.510.230.370.10N/AN/AN/A0.000.000.000.08N/A
Debt Equity Ratio
1.790.330.830.20N/AN/AN/A0.000.000.000.09N/A
Long-term Debt to Capitalization
0.600.180.41N/AN/AN/AN/AN/AN/AN/A0.01N/A
Total Debt to Capitalization
0.640.250.450.16N/AN/AN/A0.000.000.000.02N/A
Interest Coverage Ratio
-17.72-16.56N/A-22.65-644.99N/A-12.56KN/AN/AN/A-25.23-644.99
Cash Flow to Debt Ratio
-0.85-1.34-1.87-17.48N/AN/AN/A-41.81-50.10-44.69-12.45N/A
Company Equity Multiplier
3.461.462.221.881.401.791.051.061.091.171.091.79
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-45.45-70.66-81.46-46.10-34.92-54.15-44.57-64.17-87.61-63.29-87.61-54.15
Free Cash Flow / Operating Cash Flow Ratio
1.021.101.021.001.001.001.011.001.021.011.021.00
Cash Flow Coverage Ratio
-0.85-1.34-1.87-17.48N/AN/AN/A-41.81-50.10-44.69-12.45N/A
Short Term Coverage Ratio
-6.70-4.23-13.15-17.48N/AN/AN/A-41.81-50.10-44.69-50.10N/A
Dividend Payout Ratio
-160.66%-88.23%-61.83%-97.32%-147.25%-150.07%-125.72%-0.08%-1.10%N/AN/A-147.25%